Perfil
Robert Tighe is currently working as Vice President-Research at TCR2 Therapeutics, Inc. He previously worked as VP-Translational Immunology & Immunopharmacology at Compass Therapeutics, Inc.
Cargos activos de Robert Tighe
| Empresas | Cargo | Inicio |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de Robert Tighe.
| Empresas | Cargo | Fin |
|---|---|---|
| COMPASS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| COMPASS THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Robert Tighe
